Vertex Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth 3.42%
- Profit Growth 2.02%
- Ebitda -41.34%
- Net Worth 1.53%
- Total Assets 4.39%
About Vertex Lifesciences
Vertex Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2013 and has a history of 11 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Rajesh Mule and Meena Mule serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U15494MH2013PTC250420
- Company No.
250420
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Vertex Lifesciences Private Limited offer?
Vertex Lifesciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Feed Additives.
Who are the key members and board of directors at Vertex Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Mule  | Director | 26-Nov-2013 | Current |
| Meena Mule | Director | 23-Feb-2021 | Current |
Financial Performance of Vertex Lifesciences.
Vertex Lifesciences Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.42% increase. The company also saw a slight improvement in profitability, with a 2.02% increase in profit. The company's net worth moved up by a moderate rise of 1.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vertex Lifesciences?
In 2021, Vertex Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2018 | Hdfc Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Vertex Lifesciences?
Unlock and access historical data on people associated with Vertex Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vertex Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vertex Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
